Blood News and Research

RSS

Researchers discover Rasip1 protein that might prevent cancer metastasis

UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.

12 May 2011

Antiretroviral therapy can reduce risk of HIV transmission in couples

When one partner in a couple is infected with HIV and the other is not, treatment with antiretroviral drugs can dramatically lower the chances of the infected partner passing along the disease to his or her mate, a new evidence review finds.

12 May 2011

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

12 May 2011

Study links physical inactivity with high risk of cardiovascular disease in young children

Even healthy children as young as nine-years-old can start to show an increased risk of future heart problems if they are physically inactive, according to a study in the May issue of Acta Paediatrica.

12 May 2011

Relay stent-graft safe and effective for patients with aortic dissections

Aortic dissection is rare, but when it occurs, a patient's prognosis can be poor, even with timely medical diagnosis and treatment. It is the most frequently diagnosed lethal condition of the aorta.

12 May 2011

Minister for Health and Children launches first results from The Irish Longitudinal Study on Ageing

The first results from The Irish Longitudinal Study on Ageing, a national study of 8,000 older people aged 50 and over in Ireland, were launched this week by the Minister for Health and Children, Dr James Reilly.

12 May 2011

iPSC-derived liver cells hold potential as alternative to liver transplants

Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

For diagnosing head and neck ailments, tests that use radiation are always less desirable than those that don't. Otolaryngologists have a wide range of techniques available to them, including CT or "CAT" scans, MRI and ultrasound.

12 May 2011

Being mildly overweight benefits ALS patients

Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, Massachusetts General Hospital researchers found that those who were mildly obese survived longer than patients who were normal weight, underweight or even overweight.

12 May 2011

State roundup: Daniels signs Ind. law to ban Planned Parenthood funding

Indiana Gov. Mitch Daniels, a Republican considering a run for president, signed legislation Tuesday to bar Planned Parenthood from receiving federal funding in his state, a move widely seen as a bid to woo influential social conservatives. Planned Parenthood of Indiana and the American Civil Liberties Union went to court to try to block the measure from taking effect.

12 May 2011

Valor Medical's Neucrylate AN device receives CE Mark approval for treating cerebral aneurysms

Valor Medical announced today that it has received CE Mark approval for Neucrylate AN for treating cerebral aneurysms.

12 May 2011

MHI team uses cryoablation to successfully treat atrial fibrillation

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.

From Medtronic 11 May 2011

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced a second drug from its cardiometabolic program, SPC4955 into Phase 1 clinical trials, for the treatment of high cholesterol.

11 May 2011

AspirinWorks Test now available in greater Boston and surrounding area

A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine.

11 May 2011

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

The Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals, Inc. announced today that they have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide, an analog of the human hormone amylin, with insulin to treat type 1 diabetes.

11 May 2011

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced that GATTEX, a novel, recombinant analog of human glucagon-like peptide 2, was found to effectively and safely reduce parenteral support volume in adult short bowel syndrome-intestinal failure patients.

11 May 2011

Common tiny tropical fish plays a key role in new model for Cushing disease

A common, tiny tropical fish plays a key role in a new model for Cushing disease, giving researchers a powerful tool to conduct extensive searches for effective treatments for this serious hormonal disorder, testing up to 300 drugs weekly.

11 May 2011

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 2011 Digestive Disease Week conference highlighting additional analyses of data from Phase 3 trials of DIFICID, an investigational product for the treatment of Clostridium difficile infection.

11 May 2011

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.

11 May 2011

Blood News and Research

Researchers discover Rasip1 protein that might prevent cancer metastasis

Antiretroviral therapy can reduce risk of HIV transmission in couples

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Study links physical inactivity with high risk of cardiovascular disease in young children

Relay stent-graft safe and effective for patients with aortic dissections

Minister for Health and Children launches first results from The Irish Longitudinal Study on Ageing

iPSC-derived liver cells hold potential as alternative to liver transplants

Reprogrammed herpes virus can improve early cancer diagnosis

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

Being mildly overweight benefits ALS patients

State roundup: Daniels signs Ind. law to ban Planned Parenthood funding

Valor Medical's Neucrylate AN device receives CE Mark approval for treating cerebral aneurysms

MHI team uses cryoablation to successfully treat atrial fibrillation

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

AspirinWorks Test now available in greater Boston and surrounding area

Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment

GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011

Common tiny tropical fish plays a key role in new model for Cushing disease

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News